ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

MODAG-009

A development code. Also written as “[¹⁸F]MODAG-009 PET imaging” and “[¹⁸F]MODAG-009 PET Imaging”.

Its studies are mostly in Multiple System Atrophy, led by MODAG.

Furthest: early phase 1, since May 7, 20262 company-led studies, 2 open or runningNext primary completion: May 2027 (early phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
MODAG22 open or runningearly phase 1since May 7, 2026May 7, 2026May 2027early phase 1 · NCT07640555

Also a collaborator on its studies: XingImaging.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. May 7, 2026First studies: 2 early phase 1 studies in Multiple System AtrophyFirst studyNCT07640555, NCT07617688

Ahead

  1. May 2027Primary completion: early phase 1 study in Multiple System AtrophyNCT07617688
  2. May 2027Primary completion: early phase 1 study in Multiple System AtrophyNCT07640555

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07617688Multiple System Atrophy · United StatesEarly 1RecruitingMay 20276
NCT07640555Multiple System Atrophy · United StatesEarly 1RecruitingMay 202713

How it is read

Names in the registry

  • “[¹⁸F]MODAG-009 PET imaging”, 1 entry
  • “[¹⁸F]MODAG-009 PET Imaging”, 1 entry

Codes read as this program: MODAG009.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.